Aviragen Therapeutics - Company & Market Research Reports

Aviragen Therapeutics is focused on the discovery and development of the next generation of direct-acting antivirals to treat infections that have limited therapeutic options and affect a significant number of patients globally. The company has four Phase 2 clinical programs: vapendavir, vapendavir, BTA585 and BTA074. Aviragen changed its name from Biota in 2016 to reflect its transition from a drug discovery company to one focused on late-stage products treating viral diseases. Founded in 1969, Aviragen Therapeutics is headquartered in Alpharetta, Georgia.

Global Human Respiratory Syncytial Virus Drugs Market 2016-2020 - Product Thumbnail Image

Global Human Respiratory Syncytial Virus Drugs Market 2016-2020

  • Report
  • 74 Pages
From
Genital Warts (Condylomata Acuminata) - Pipeline Review, H2 2016 - Product Thumbnail Image

Genital Warts (Condylomata Acuminata) - Pipeline Review, H2 2016

  • Drug Pipelines
  • 62 Pages
From
Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Pipeline Review, H2 2016 - Product Thumbnail Image

Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Pipeline Review, H2 2016

  • Drug Pipelines
  • 132 Pages
From
Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2016 - Product Thumbnail Image

Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2016

  • Drug Pipelines
  • 70 Pages
From
Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2018 - Product Thumbnail Image

Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2018

  • Drug Pipelines
  • 40 Pages
From
Human Papillomavirus Associated Diseases - Pipeline Insights, 2018 - Product Thumbnail Image

Human Papillomavirus Associated Diseases - Pipeline Insights, 2018

  • Drug Pipelines
  • 199 Pages
From
Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H1 2018

  • Drug Pipelines
  • 42 Pages
From
Nicotine Addiction Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Nicotine Addiction Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 216 Pages
From
Genital Warts (Condylomata Acuminata) Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Genital Warts (Condylomata Acuminata) Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 80 Pages
From
Rhinovirus Infection - Pipeline Insight, 2018 - Product Thumbnail Image

Rhinovirus Infection - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Antibiotic Resistance Markets - Therapeutics By Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization. 2018 to 2023 - Product Thumbnail Image

Antibiotic Resistance Markets - Therapeutics By Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization. 2018 to 2023

  • Report
  • 284 Pages
From
Antibiotic Resistance Markets - Pharmaceutical Therapeutics - By Pathogen and Therapy Type Strategies & Trends 2018 to 2023 - Product Thumbnail Image

Antibiotic Resistance Markets - Pharmaceutical Therapeutics - By Pathogen and Therapy Type Strategies & Trends 2018 to 2023

  • Report
  • 279 Pages
From
Condyloma - Pipeline Insight, 2018 - Product Thumbnail Image

Condyloma - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Influenzavirus B Infections Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Influenzavirus B Infections Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 95 Pages
From
Rhinovirus Infections Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Rhinovirus Infections Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • 47 Pages
From
Prosthesis-Related Infections Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Prosthesis-Related Infections Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 35 Pages
From
Human Papillomavirus Infections Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Human Papillomavirus Infections Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 273 Pages
From
Q2 2017 Earnings Call - Aviragen Therapeutics, Inc., - Earnings Transcript - Product Thumbnail Image

Q2 2017 Earnings Call - Aviragen Therapeutics, Inc., - Earnings Transcript

  • Earnings Transcript
Aviragen Therapeutics Inc (AVIR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Aviragen Therapeutics Inc (AVIR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • 84 Pages
From
Aviragen Therapeutics Inc (AVIR) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Aviragen Therapeutics Inc (AVIR) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 47 Pages
From
Loading Indicator
adroll